Comparison of randomized controlled trials discontinued or revised for poor recruitment and completed trials with the

Matthias Briel1,2, Benjamin Speich3, Erik von Elm4

  • 1Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University of Basel and University Hospital Basel, Basel, Switzerland. matthias.briel@usb.ch.

Trials
|January 1, 2020
PubMed
Abstract

Insights

Poor patient recruitment halts many randomized controlled trials (RCTs). This study found narrower criteria, investigator sponsorship, and higher patient burden contribute to recruitment failure in RCTs.

Area of Science:

  • Clinical Trials Methodology
  • Research Study Design
  • Patient Recruitment Strategies

Background:

  • Over a quarter of randomized controlled trials (RCTs) are discontinued due to poor patient recruitment.
  • Understanding the causes of recruitment failure is crucial for successful trial completion.

Purpose of the Study:

  • To systematically compare RCTs discontinued or revised for poor recruitment with completed RCTs addressing similar research questions.
  • To identify methodological and contextual factors contributing to poor patient recruitment in clinical trials.

Main Methods:

  • Compared discontinued/revised RCTs with completed RCTs matched for population and intervention.
  • Conducted literature searches for systematic reviews and identified matching completed RCTs.
  • Extracted data to explore differences in design, conduct, and study settings between RCTs with and without recruitment issues.

Main Results:

  • Analyzed 29 discontinued/revised RCTs and 48 completed RCTs across 15 research questions, prominent in cancer and acute care.
  • RCTs with poor recruitment featured narrower eligibility criteria, investigator sponsorship, higher patient/recruiter burden, and later initiation.
  • Reporting quality of recruitment processes in publications was generally low; multi-center settings were not always advantageous.

Conclusions:

  • Confirmed narrow eligibility criteria, investigator sponsorship, and reduced patient/recruiter motivation as causes of poor recruitment.
  • Highlighted the need for researchers to be aware of concurrent RCTs to minimize recruitment interference.
  • Indicated that a larger number of centers is not universally beneficial for patient recruitment.

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
507
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
348
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
130
Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
8.8K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
173
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.0K